Posted by: drchasrani on: June 15, 2012
Hip fractures are a major public health problem. By 2050, 6.3 to 8.2 million hip fractures will occur annually worldwide. Studies have indicated that mortality rate is increased 1 year after hip fractures in women. […]
Posted by: admin on: December 6, 2011
A selective estrogen receptor modulator (SERM) bazedoxifene is on the trial, to be approved as a drug for prevention of postmenopausal osteoporosis. Here is an article showing the clinical efficacy and safety of bazedoxifene in the treatment of postmenopausal osteoporosis. Team@CMHF
Posted by: admin on: December 2, 2011
Fracture of the bones within the joint is a challenge to the orthopedic surgeon. Sub optimal reduction, osteoarthritis are complications, that may leave both the doctor and the patient unhappy. With the 3D fluoroscopy, procedures could get more successful. Read on to see how. Team@CMHF
Posted by: admin on: June 22, 2011
Osteoporosis and women have a long drawn association. While treating men with glucocorticoids little do we consider osteoporosis risk. A second thought on this side effect is a must, while treating a case of fracture or with on going steroid treatment in men. Team@CMHF
Posted by: admin on: June 17, 2011
This trial is the first exercise study that focuses on fracture incidence as a primary study endpoint. Findings further increased the evidence that exercise relevantly prevents fractures in the elderly. INTRODUCTION: The purpose of this study is to determine the effect of strictly supervised long-term exercise training on “overall” fracture incidence and bone mineral density […]